We are committed to developing cutting-edge diagnostic tools that address the critical needs of patients, clinicians, and practice administrators. 

Our Mission

Quantitative Insights is dedicated to improving the speed and accuracy of breast cancer diagnosis by developing the most intuitive breast MRI workstation ever: QuantX™. By harnessing the power of cutting-edge research and advanced imaging solutions, QI is committed to improving the diagnostic performance of radiologists and enabling better outcomes for patients.


QI, with its FDA-cleared QuantX™, marks an important inflection point for the use of artificial intelligence in routine clinical settings to improve the diagnosis and treatment of cancer and save lives.
— Dr. Maryellen Giger, Quantitative Insights Co-Founder

The technology developed by Quantitative Insights is based on more than two decades of scientific research from the laboratory of Maryellen Giger, Ph.D., at the University of Chicago. QI’s management team and advisors have been responsible for many of the transformative changes in the CAD industry over the past few decades.